Filing Details

Accession Number:
0000950170-23-012595
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-04-12 19:05:46
Reporting Period:
2023-04-12
Accepted Time:
2023-04-12 19:05:46
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1590750 Viridian Therapeutics Inc. VRDN () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1356256 Dunseth Scott Myers C/O Viridian Therapeutics, Inc.
221 Crescent Street, Suite 401
Waltham MA 02453
Chief Executive Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-04-12 4,000 $25.37 259,500 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct